----item----
version: 1
id: {974A494B-D2C5-4975-8C18-F4FFC1645CD4}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/09/01/UCBs new CEO appoints executive team
parent: {684FC8D5-D802-45B5-B1B4-59D6EC33E6A8}
name: UCBs new CEO appoints executive team
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: e3511edd-422a-4ad1-b924-a34b955b682c

----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 77

{CD796374-A60A-4D81-8A05-7B92AD2013C1}|{649253E7-61BB-41CA-ACAF-6CC3C62670AE}
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 38

UCB's new CEO appoints executive team 
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 36

UCBs new CEO appoints executive team
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 1661

<p>UCB's new chief executive Jean-Christophe Tellier, who took up the post 1 January 2015, has revealed new appointments at the company, and has confirmed the company's leadership team. Mr Tellier, who succeeds Roch Doliveux as CEO, has been with UCB since 2011. </p><p>The new structure, which will be effective from 1 February, will be as follows:</p><p><b>Patient Value Units:</b></p><ul><li>New Medicines: Ismail Kola, new medicines head and chief scientific officer</li><li>Neurology: Jeff Wren, patient value unit head, previously head of UCB's North American region</li><li>Immunology: Emmanuel Caeymaex, patient value unit head, previously head of UCB' s Cimzia (certolizumab pegol) team</li><li>Bone disorders : this position is still to be filled and will be led in the interim by Iris Loew Friedrich, UCB's chief medical officer</li></ul><p><b>Patient Value Practices:</b></p><ul><li>Strategic Marketing: Bharat Tewarie, chief marketing officer. A physician with strong industry experience, he joins UCB from Merck-Serono where he was senior vice-president, head of global business franchise neurology and immunology and head of global business franchise medical devices</li><li>Development and Medical: Iris Loew Friedrich, CMO</li></ul><p><b>Patient Value Operations:</b></p><ul><li>Geographic Operations, Established Brands, Technical Operations and Business Development: Mark McDade, chief operating officer</li></ul><p><b>Patient Value Functions:</b></p><ul><li>Finance: Detlef Thielgen, chief financial officer</li><li>Talent and Company Reputation: Fabrice Enderlin, chief talent officer</li><li>Legal: Anna Richo, general counsel</li></ul><p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 267

<p>UCB's new chief executive Jean-Christophe Tellier, who took up the post 1 January 2015, has revealed new appointments at the company, and has confirmed the company's leadership team. Mr Tellier, who succeeds Roch Doliveux as CEO, has been with UCB since 2011. </p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 36

UCBs new CEO appoints executive team
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20150901T080000
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20150901T080000
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20150901T080000
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC027510
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 38

UCB's new CEO appoints executive team 
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{090E9A04-9B4B-4986-8BAF-06A6B07B978D}
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 13

Headline News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

356034
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042231Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

e3511edd-422a-4ad1-b924-a34b955b682c
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042231Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
